西藏水资源(01115)发布公告，于2025年11月24日，因2025年3月18日发行的2025年到期1.38亿港元8%可 换股债券获悉数转换而配发及发行新股4亿股。 ...

Core Viewpoint - Global Medical (02666) announced the conversion of convertible bonds into shares, indicating a strategic move to raise equity capital through the exercise of conversion rights by Dragonland International Development Limited [1] Group 1: Convertible Bonds Conversion - On November 7, 2025, the company received a conversion notice from Dragonland International Development Limited regarding the exercise of conversion rights attached to convertible bonds [1] - The total principal amount of $90 million in convertible bonds will be converted into approximately 123 million shares at a conversion price of HKD 5.7 per share [1] - Following the conversion, approximately 123 million shares will be issued on November 12, 2025, representing about 6.48% of the company's issued share capital prior to the conversion and approximately 6.09% after the issuance [1] Group 2: Share Characteristics - The newly issued shares will rank equally with the existing shares on the date of issuance and will carry the same rights, including entitlement to dividends and distributions [1]

Core Points - The company announced that all conditions precedent under Share Purchase Agreement I and Share Purchase Agreement II have been fulfilled, and the agreements were completed on October 2, 2025 [1] - A total of 2.753 billion shares were issued as consideration shares [1] - The company received a conversion notice from bondholders to fully exercise their conversion rights under the convertible bond, converting HKD 1.086 billion principal amount into 5.173 billion conversion shares at a conversion price of HKD 0.21 per share [1] - After completing the necessary administrative procedures for the issuance of conversion shares, the company issued 5.173 billion conversion shares to bondholders on October 2, 2025, which rank equally with all other existing shares [1]

Core Viewpoint - The company, Bestar Holdings (01168.HK), anticipates a significant increase in losses for the six months ending June 30, 2025, projecting a loss of no more than HKD 535 million compared to a loss of approximately HKD 150.5 million in the same period last year, primarily due to fair value losses on convertible bonds [1] Financial Performance - The projected loss for the upcoming reporting period is attributed mainly to a fair value loss of approximately HKD 497.9 million related to convertible bonds [1] - The company will recognize an additional non-cash accounting adjustment loss of about HKD 476.5 million in its annual results for the year ending December 31, 2025, due to the conversion of convertible bonds [1] Corporate Actions - On July 24, 2025, all holders of the convertible bonds exercised their conversion rights, resulting in the issuance of 117,647,058 shares on July 25, 2025 [1]